| Primary |
| Infertility |
32.3% |
| In Vitro Fertilisation |
26.9% |
| Product Used For Unknown Indication |
11.5% |
| Ovulation Induction |
10.0% |
| Assisted Fertilisation |
6.2% |
| Drug Use For Unknown Indication |
4.6% |
| Infertility Female |
3.8% |
| Vitamin Supplementation |
1.5% |
| Anovulatory Cycle |
0.8% |
| Jugular Vein Thrombosis |
0.8% |
| Ovarian Hyperstimulation Syndrome |
0.8% |
| Therapeutic Procedure |
0.8% |
|
| Ovarian Hyperstimulation Syndrome |
29.3% |
| Abortion Spontaneous |
7.3% |
| Maternal Drugs Affecting Foetus |
7.3% |
| Pregnancy |
7.3% |
| Dyspnoea |
4.9% |
| Mydriasis |
4.9% |
| Somnolence |
4.9% |
| Weight Decreased |
4.9% |
| Abdominal Discomfort |
2.4% |
| Abdominal Distension |
2.4% |
| Breast Cancer Female |
2.4% |
| Cyst |
2.4% |
| Cystosarcoma Phyllodes |
2.4% |
| Drug Ineffective |
2.4% |
| Dyspnoea Exertional |
2.4% |
| Exposure During Pregnancy |
2.4% |
| Extrasystoles |
2.4% |
| Fatigue |
2.4% |
| Gait Disturbance |
2.4% |
| Headache |
2.4% |
|
| Secondary |
| In Vitro Fertilisation |
33.6% |
| Product Used For Unknown Indication |
20.6% |
| Infertility |
13.4% |
| Ovulation Induction |
11.3% |
| Infertility Female |
3.4% |
| Ovarian Hyperstimulation Syndrome |
3.4% |
| Assisted Fertilisation |
2.5% |
| Drug Use For Unknown Indication |
1.7% |
| Hypertension |
1.7% |
| Infertility Male |
1.7% |
| Ovarian Disorder |
1.3% |
| Coagulopathy |
0.8% |
| Hormone Suppression Therapy |
0.8% |
| Ovarian Failure |
0.8% |
| Prophylaxis |
0.8% |
| Angiopathy |
0.4% |
| Anovulatory Cycle |
0.4% |
| Drug Therapy |
0.4% |
| Growth Hormone Deficiency |
0.4% |
| Nausea |
0.4% |
|
| Deep Vein Thrombosis |
9.4% |
| Ovarian Hyperstimulation Syndrome |
9.4% |
| Abdominal Pain |
7.5% |
| Weight Decreased |
7.5% |
| Oesophageal Ulcer |
5.7% |
| Pulmonary Mass |
5.7% |
| Tremor |
5.7% |
| Abdominal Distension |
3.8% |
| Abortion Spontaneous |
3.8% |
| Cerebrovascular Accident |
3.8% |
| Drug Ineffective |
3.8% |
| Eosinophilic Pneumonia Acute |
3.8% |
| No Therapeutic Response |
3.8% |
| Pleural Effusion |
3.8% |
| Pregnancy |
3.8% |
| Thrombocytosis |
3.8% |
| Thyroiditis |
3.8% |
| Visual Acuity Reduced |
3.8% |
| Vomiting |
3.8% |
| White Blood Cell Count Increased |
3.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
42.0% |
| In Vitro Fertilisation |
30.7% |
| Infertility |
3.4% |
| Ovulation Induction |
2.9% |
| Artificial Insemination By Partner |
2.5% |
| Assisted Fertilisation |
2.5% |
| Supplementation Therapy |
2.5% |
| Vitamin Supplementation |
1.7% |
| Contraception |
1.3% |
| Drug Use For Unknown Indication |
1.3% |
| Thyroid Disorder |
1.3% |
| Vitamin D Deficiency |
1.3% |
| Blood Follicle Stimulating Hormone |
0.8% |
| Blood Follicle Stimulating Hormone Abnormal |
0.8% |
| Hypopituitarism |
0.8% |
| Irritable Bowel Syndrome |
0.8% |
| Mineral Supplementation |
0.8% |
| Oestrogen Replacement Therapy |
0.8% |
| Oocyte Harvest |
0.8% |
| Ovarian Hyperstimulation Syndrome |
0.8% |
|
| Headache |
13.3% |
| Drug Exposure During Pregnancy |
8.9% |
| Rash |
8.9% |
| Ovarian Disorder |
6.7% |
| Ovarian Hyperstimulation Syndrome |
6.7% |
| Antepartum Haemorrhage |
4.4% |
| Diplopia |
4.4% |
| Drug Ineffective |
4.4% |
| Hot Flush |
4.4% |
| Incorrect Dose Administered By Device |
4.4% |
| Infertility Female |
4.4% |
| Injection Site Pain |
4.4% |
| Malaise |
4.4% |
| Mood Swings |
4.4% |
| Tremor |
4.4% |
| Abdominal Distension |
2.2% |
| Abortion Missed |
2.2% |
| Abortion Spontaneous |
2.2% |
| Bile Duct Stone |
2.2% |
| Contraindication To Medical Treatment |
2.2% |
|
| Interacting |
| In Vitro Fertilisation |
100.0% |
|
| Ovarian Hyperstimulation Syndrome |
100.0% |
|
